Q1 2021 INVO Bioscience Inc Earnings Call Transcript

May 17, 2021 / 08:30PM GMT
Operator

Good afternoon and welcome to the INVO Bioscience reports first-quarter of fiscal year 2021 financial results conference call. (Operator Instructions) Please note this event is being recorded.

I would now like to turn the conference over to Joe Diaz from Lytham Partners. Please go ahead.

Joe Diaz - Lytham Partners, LLC - IR

Thank you, and thanks, everyone, for joining us today for a review of INVO Bioscience's first-quarter 2021 financial results. Joining us on the call today is INVO Bioscience's Chief Executive Officer, Steve Shum. At the conclusion of today's prepared remarks, we will open the call for a question-and-answer session.

Before we begin with the event, we submit for the record the following statements. Certain matters discussed on this conference call by management of INVO Bioscience may be forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 as amended, Section 21E of the Securities Exchange Act of 1934 as amended, and such forward-looking statements are made pursuant to the Safe Harbor

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot